Home

Insights

Astrazeneca Pharma India Ltd P/E Ratio

Astrazeneca Pharma India Ltd P/E Ratio

download
stocks purchased

₹ 0.7 Cr

Volume transacted

stocks purchased

1.3 K

stocks traded

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

PE

85.3

Last updated : 17 May 15:30 pm

Key Highlights

    The P/E Ratio of Astrazeneca Pharma India Ltd is 85.3 as of 17 May 15:30 pm .a1#The P/E Ratio of Astrazeneca Pharma India Ltd changed from 91.8 on March 2019 to 81.8 on March 2023 . This represents a CAGR of -2.28% over 5 years. a1#The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 5757 as of 17 May 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 4995 crore on March 2019 to ₹ 8118 crore on March 2023 . This represents a CAGR of 10.20% over 5 years. a1#The Revenue of Astrazeneca Pharma India Ltd changed from ₹ 236.45 crore to ₹ 315.45 crore over 7 quarters. This represents a CAGR of 17.91% a1#The EBITDA of Astrazeneca Pharma India Ltd changed from ₹ 32.08 crore to ₹ 24.72 crore over 7 quarters. This represents a CAGR of -13.84% a1#The Net Profit of Astrazeneca Pharma India Ltd changed from ₹ 20.15 crore to ₹ 15.8 crore over 7 quarters. This represents a CAGR of -12.97% a1#The Dividend Payout of Astrazeneca Pharma India Ltd changed from 3.46 % on March 2019 to 40.29 % on March 2023 . This represents a CAGR of 84.73% over 4 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1991.8
Mar '2082.8
Mar '2180.7
Mar '22103.7
Mar '2381.8

Fundamental Metrics

Market Cap

14,394 Cr

EPS

63.8

P/E Ratio (TTM) *

85.3

P/B Ratio (TTM) *

20.8

Day’s High

5866.4

Day’s Low

5633.35

DTE *

0.0

ROE *

26.4

52 Week High

7208.0

52 Week Low

3131.1

ROCE *

35.2

* All values are consolidated

* All values are consolidated

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

PRICE

5757.75

118.50(2.10%)

stock direction

Last updated : 17 May 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Astrazeneca Pharma India Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

Asset Value vs Market Value

Market Value

13,611

Asset Value

858

14.9 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

139 Cr

85.3 X

PE Ratio

Market Cap

₹13611Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

139 Cr

85.3 X

PE Ratio

Market Cap

₹13611Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Astrazeneca Pharma India Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Astrazeneca Pharma India Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Astrazeneca Pharma India Ltd's Share Price stands at 5757.75. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-17T00:00:00 is 63.8. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 5757.75/ 63.8= 85.34.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Astrazeneca Pharma India Ltd's stock is trading at approximately 85.34 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Astrazeneca Pharma India Ltd’s PE Ratio (BSE: ASTRAZEN)

    The Price-to-Earnings (PE) ratio, used to assess Astrazeneca Pharma India Ltd's stock (BSE: ASTRAZEN), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '194996
Mar '205979
Mar '217526
Mar '226389
Mar '238118

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '22236
Sep '22243
Dec '22257
Mar '22293
Jun '23304
Sep '23336
Dec '23315

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '2232
Sep '2248
Dec '2244
Mar '2228
Jun '2375
Sep '2378
Dec '2325

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '2220
Sep '2233
Dec '2229
Mar '2217
Jun '2354
Sep '2352
Dec '2316

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '190
Mar '203
Mar '215
Mar '2241
Mar '2340

* All values are a in %

About Astrazeneca Pharma India Ltd

About Astrazeneca Pharma India Ltd

    The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company. The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. During 2001-02 the company has commissioned the automatic ampoule filling machine and thereby increased the capacity of the same from 10 Mio to 12 Mio. The Year 2013-14 was the first full year post supply stabilization from AstraZeneca Pharma India's (APIL) factory operations, which had impacted the performance of the company since March 2012. Neither the company nor any of its officials/employees have been named as accused in the charge sheet. APIL had since 2010 been associated with BMS in promotions of Onglyza (Saxagliptin), Kombiglyze XR (Saxagliptin and Metformin HCl extended release) and Byetta in the Indian Pharmaceutical Market. During the year under, the company's manufacturing site at Yelahanka resolved many constraints in the supply, consistently meeting supply requirements. Forxiga is part of a newer class of medicines known as SGLT2 (Sodium Glucose Cotransporter 2) inhibitors that act to block reabsorption of sugar in the kidneys.

Astrazeneca Pharma India Ltd News Hub

News

Astrazeneca Pharma India declare Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 2...

Read more

16 May 2024 14:53

News

AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine

However, AstraZeneca will retain the intellectual property rights to budesonide and formot...

Read more

12 Mar 2024 13:02

News

AstraZeneca Pharma India and Mankind Pharma ink distribution agreement

AstraZeneca Pharma India�and Mankind Pharma�entered into an agreement for exclusive distri...

Read more

11 Mar 2024 15:39

News

AstraZeneca Pharma slumps after Q3 PAT slides 46% YoY to Rs 16 cr

Revenue from operations jumped 22.41% to Rs 305.78 crore during the quarter as compared wi...

Read more

09 Feb 2024 10:32

News

Astrazeneca Pharma India Ltd leads losers in 'A' group

MSTC Ltd, Power Finance Corporation Ltd, KIOCL Ltd and Rail Vikas Nigam Ltd are among the ...

Read more

09 Feb 2024 15:00

News

Astrazeneca Pharma India to declare Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 8...

Read more

27 Jan 2024 12:06

Product Composition by Percentage (Revenue)

FAQs for PE of Astrazeneca Pharma India Ltd

What is Astrazeneca Pharma India Ltd current share price?

The current market price of Astrazeneca Pharma India Ltd as of May 17, 2024 is ₹5757.75.

What is Astrazeneca Pharma India Ltd's market cap?

Astrazeneca Pharma India Ltd's market capitalisation stood at ₹13,611 Cr as of May 17, 2024

What are Astrazeneca Pharma India Ltd's total net assets?

According to Astrazeneca Pharma India Ltd's most recent financial filings, the company's net assets total ₹857.7 Cr.

Is Astrazeneca Pharma India Ltd making a profit or loss?

Astrazeneca Pharma India Ltd's net Profit as of May 17, 2024 is close to ₹139 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199